IL277362B - Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist - Google Patents
Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonistInfo
- Publication number
- IL277362B IL277362B IL277362A IL27736220A IL277362B IL 277362 B IL277362 B IL 277362B IL 277362 A IL277362 A IL 277362A IL 27736220 A IL27736220 A IL 27736220A IL 277362 B IL277362 B IL 277362B
- Authority
- IL
- Israel
- Prior art keywords
- antagonist
- administering
- methods
- treating chronic
- chronic sinusitis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462080092P | 2014-11-14 | 2014-11-14 | |
US201462083821P | 2014-11-24 | 2014-11-24 | |
US201562158832P | 2015-05-08 | 2015-05-08 | |
US201562199305P | 2015-07-31 | 2015-07-31 | |
EP15306632 | 2015-10-14 | ||
PCT/US2015/060540 WO2016077675A1 (en) | 2014-11-14 | 2015-11-13 | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
IL277362A IL277362A (en) | 2020-11-30 |
IL277362B true IL277362B (en) | 2021-08-31 |
Family
ID=71117011
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL285483A IL285483B (en) | 2014-11-14 | 2015-11-13 | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
IL277362A IL277362B (en) | 2014-11-14 | 2020-09-15 | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL285483A IL285483B (en) | 2014-11-14 | 2015-11-13 | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP7216122B2 (en) |
HK (1) | HK1243716A1 (en) |
IL (2) | IL285483B (en) |
-
2015
- 2015-11-13 IL IL285483A patent/IL285483B/en unknown
-
2018
- 2018-02-24 HK HK18102664.1A patent/HK1243716A1/en unknown
-
2020
- 2020-09-15 IL IL277362A patent/IL277362B/en unknown
-
2021
- 2021-01-08 JP JP2021001858A patent/JP7216122B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
IL285483A (en) | 2021-09-30 |
IL285483B (en) | 2022-08-01 |
JP7216122B2 (en) | 2023-01-31 |
JP2021063122A (en) | 2021-04-22 |
IL277362A (en) | 2020-11-30 |
HK1243716A1 (en) | 2018-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL252228B (en) | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist | |
HK1222567A1 (en) | Methods for treating nasal polyposis by administering an il-4r antagonist il-4r | |
PL3107575T3 (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
GB2524295B (en) | An inhaler | |
GB2524293B (en) | An inhaler | |
GB2524296B (en) | An inhaler | |
PT3110483T (en) | Inhaler | |
HK1215864A1 (en) | Cannula for catgut-embedding therapy | |
ZA201603150B (en) | Inhaler device | |
PL3182957T3 (en) | Cineole-containing composition for nasal application | |
DK3215223T3 (en) | BUPRENORPHIN DOSAGE SCHEMES | |
GB2528068B (en) | An inhaler | |
HK1223837A1 (en) | Compositions and methods for reducing overdose | |
ZA201608785B (en) | Nasal administration | |
AU358579S (en) | Inhaler | |
SG11201700059WA (en) | Therapeutic agent for keratoconjunctive disorder | |
IL285483A (en) | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist | |
GB201409603D0 (en) | An inhalable medicament | |
IL247290A0 (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
SG10201912898XA (en) | Methods for treating nasal polyposis by administering an il-4r antagonist | |
IL249533A0 (en) | Treatment for chronic lymphocytic leukemia (cll) | |
AU367030S (en) | Nasal interface | |
GB201508562D0 (en) | Inhaler |